Approval for the lt-cage peek lumber tapered fusion device, which is manufactured from polyetheretherke-tone, with the trade name of peek-optima lt1.  The device, as modified, will be marketed under the trade name lt-cage peek lumbar tapered fusion device and is indicated for spinal fusion procedures in skeletally mature patients with degernerative disc disease (ddd) at one level from l2-s1.  Ddd is defined as discogenic back pain with degeneration of the disc confirmed by patient history and radiographic studies.  These ddd patients also have up to grade i spondylolisthesis or retrolisthesis at the involved level.  Lt-cage peek implants are to be used with autogenous bone graft and implanted via a laparoscopic or an open anterior approach.  Patients receiving the lt-cage peek lumbar tapered fusion device should have at least six months of non-operative treatment prior treatment with the lt-cage peek device.